Français
ItalianoBond Gilead Biosciences Inc 0.713% ( US375558BV46 ) in USD
| Issuer | Gilead Biosciences Inc |
| Market price | 100 % ▼ |
| Country |  United States
|
| ISIN code |
 US375558BV46 ( in USD )
|
| Interest rate | 0.713% per year ( payment 4 times a year) |
| Maturity | 28/09/2023 - Bond has expired |
|
Prospectus brochure in PDF format is unavailable at this time We will provide it as soon as possible |
|
| Minimal amount | 1 000 USD |
| Total amount | 500 000 000 USD |
| Cusip | 375558BV4 |
| Standard & Poor's ( S&P ) rating | BBB+ ( Lower medium grade - Investment-grade ) |
| Moody's rating | A3 ( Upper medium grade - Investment-grade ) |
| Detailed description |
Gilead Sciences, Inc. is a biopharmaceutical company that discovers, develops, and commercializes innovative therapeutics in areas of unmet medical need, primarily focusing on HIV/AIDS, hepatitis B and C, and oncology. Gilead Sciences Inc.'s US$500,000,000 0.713% bonds (CUSIP: 375558BV4, ISIN: US375558BV46), issued in the United States and maturing on September 28, 2023, with a minimum purchase size of $1,000 and a coupon frequency of four, have matured and been repaid at 100% of face value, rated BBB+ by S&P and A3 by Moody's. |